CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ | |
Journals - Article | |
Česky / Czech version | Prakt. Lék., 81, 2001, No. 7, p. 396-399 |
Xatral (Alfuzosin) 2.5 mg in the Treatment of BPH Novák J. Urologická klinika VFN, Praha, přednosta prof. MUDr. J. Dvořáček, DrSc |
|
Summary: 772 patients from 68 urological departments took part in the study with alfuzosin 2.5 mg three
times daily for treatment symptoms of BPH. The study lasted 3 months. The results and
patients’ quality of life were compared with the IPSS score and AUA symptom score. Adverse
events were minimal. The number of orthostatic hypotension was relatively low (1.8%). The
benefit of the treatment for the patients with BPH treated with alfuzosin 2.5 mg t.i.d. was
relatively good with a minimal number of adverse events.
|
|
Order this issue
|
BACK TO CONTENTS | ||
| HOME PAGE | CODE PAGE | CZECH VERSION | |
© 1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ |
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o. |
WEBMASTER |